Tag: product candidates

June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: Caladrius Soars 77 Percent

Caladrius Biosciences, Bellerophon Therapeutics, Celsion, Albireo Pharma and Trillium Therapeutics were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 23, 2018

Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO

The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 9, 2018

AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates

AnaptysBio (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, reported operating...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 18, 2018

Biotech Update: Q1 in Review

With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...
April 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Novelion on Top

Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week's top gainers.
April 13, 2018

EyeGate Announces $11.25 Million Public Offering

EyeGate Pharmaceuticals (NASDAQ:EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the...
April 12, 2018

PolarityTE Announces Public Offering of Common Stock

PolarityTE (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing...